PharmaResearch Co., Ltd. (KOSDAQ:214450)
South Korea flag South Korea · Delayed Price · Currency is KRW
349,500
0.00 (0.00%)
At close: Feb 27, 2026

PharmaResearch Ratios and Metrics

Millions KRW. Fiscal year is Jan - Dec.
Fiscal Year
CurrentFY 2024FY 2023FY 2022FY 2021FY 2020
Period Ending
Feb '26 Dec '24 Dec '23 Dec '22 Dec '21 Dec '20
3,631,1822,727,2831,116,952697,316818,025552,155
Market Cap Growth
43.53%144.17%60.18%-14.76%48.15%60.62%
Enterprise Value
3,331,7672,575,782990,868612,568761,136536,011
Last Close Price
349500.00259933.95107975.2268322.0379394.2654984.38
PE Ratio
24.0629.6314.5917.1817.5216.85
Forward PE
17.8522.0612.5510.9214.4915.04
PS Ratio
7.327.794.283.585.315.08
PB Ratio
5.274.782.421.882.492.09
P/TBV Ratio
5.785.382.772.273.102.67
P/FCF Ratio
28.8726.8221.1216.5518.32-
P/OCF Ratio
22.5419.7517.2011.7412.5317.05
EV/Sales Ratio
6.727.363.803.154.944.93
EV/EBITDA Ratio
15.7218.449.508.0112.2712.83
EV/EBIT Ratio
16.9820.4310.749.2914.5016.04
EV/FCF Ratio
26.4925.3318.7414.5317.05-
Debt / Equity Ratio
0.310.370.070.180.200.12
Debt / EBITDA Ratio
1.001.490.330.871.060.78
Debt / FCF Ratio
1.682.050.651.581.47-
Net Debt / Equity Ratio
-0.48-0.40-0.27-0.32-0.28-0.18
Net Debt / EBITDA Ratio
-1.55-1.64-1.21-1.54-1.47-1.12
Net Debt / FCF Ratio
-2.61-2.25-2.38-2.79-2.0419.58
Asset Turnover
0.610.500.520.430.410.37
Inventory Turnover
1.911.841.902.552.402.07
Quick Ratio
6.555.842.964.043.862.87
Current Ratio
7.576.753.894.564.313.55
Return on Equity (ROE)
23.58%17.23%18.53%12.41%15.80%13.17%
Return on Assets (ROA)
15.05%11.33%11.38%9.10%8.78%7.08%
Return on Invested Capital (ROIC)
41.17%28.57%23.98%21.57%19.29%13.79%
Return on Capital Employed (ROCE)
21.90%16.30%19.70%15.60%13.80%11.80%
Earnings Yield
4.17%3.38%6.85%5.82%5.71%5.94%
FCF Yield
3.46%3.73%4.74%6.04%5.46%-0.43%
Dividend Yield
0.31%0.42%0.88%0.97%0.76%0.91%
Payout Ratio
7.94%10.96%9.84%15.56%10.77%9.04%
Buyback Yield / Dilution
-4.63%2.50%-5.85%0.76%-5.74%-0.73%
Total Shareholder Return
-4.31%2.93%-4.96%1.73%-4.99%0.18%
Source: S&P Global Market Intelligence. Standard template. Financial Sources.